TD Cowen analyst Charles Rhyee raised the firm’s price target on Cardinal Health (CAH) to $225 from $183 and keeps a Buy rating on the shares. The firm update their estimates following a F1Q26 where the company raised its adj. EPS guide, Pharma guide, and Other AOI guide.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- Cardinal Health Reports Strong Earnings and Raises Guidance
- Cardinal Health price target raised to $220 from $190 at Evercore ISI
- Cardinal Health price target raised to $220 from $185 at UBS
- Cardinal Health price target raised to $232 from $208 at Baird
- Cardinal Health price target raised to $190 from $165 at Citi